Companies/Ascend Wellness Holdings, Inc.

Company profile

Ascend Wellness Holdings, Inc.

OTC: AAWH · Healthcare · Drug Manufacturers - Specialty & Generic

PublicHQ Morristown, NYCIK 0001756390Reports USD

#212 of 1,394 Healthcare companies by revenue31st-percentile growth

EA Score

53D

FH 61DQ 44GM 46SS 57

v0.1 · 65/100 weight · provisional

↑ workforce scale, operating margin · ↓ listing tenure, disclosure history

Methodology →

Revenue TTM

$489.5M

Rev growth YoY (TTM)

-10.5%

Net income (FY)

-$118.2M

Employees

2,300

Market cap

$95.6M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$500.6M$500.6M2025

Net income-$118.2M-$118.2M2025

Operating income-$17.0M-$17.0M2025

Total assets$907.9M$907.9M2025

Liabilities$954.5M$954.5M2025

Equity-$47.4M-$47.4M2025

Revenue trend

FY2021 – FY2025 · USD

$12.0M

FY21

$143.7M

FY21

$332.4M

FY21

$405.9M

FY22

$518.6M

FY23

$561.6M

FY24

$500.6M

FY25

Revenue by segment

Filed disclosures · FY2025

By product

Retail100%

By geography

Not disclosed.

The read

Ascend Wellness Holdings, Inc. booked $500.6M in FY2025 revenue, contracting 11% year over year — slower than 69% of Healthcare companies we track, at a -23.6% net margin.

Peers · Healthcare

biote Corp.63C Cumberland Pharmaceuticals Inc.70B Eloxx Pharmaceuticals, Inc.28D CareCloud, Inc.73B

Key facts

CEOSamuel Brill

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersMorristown, NY

ExchangeOTC: AAWH

Employees2,300

IPO date2021-05-26

Latest filings

DEF 14A2026-07-09 8-K2026-06-25 10-Q2026-05-13 8-K2026-05-13 8-K2026-05-05 DEF 14A2026-03-20 8-K2026-03-12 10-K2026-03-12

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.